BHFAP vs BOH

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of just 3/9, indicating significant fundamental deterioration. Despite deeply discounted valuation metrics—P/E of 1.32 and Price/Book of 0.15—the company faces declining revenue (YoY -10.10%) and concerning capital structure risks, including high debt/equity of 1.47. The absence of an Altman Z-Score prevents a full distress risk assessment, but weak ROA of 0.73% and negative long-term price performance suggest underlying operational fragility. While the 9.89% dividend yield and recent short-term price rebound offer temporary appeal, these are outweighed by structural challenges and lack of analyst coverage or insider support.

BOH exhibits a mixed financial profile with a weak Piotroski F-Score of 4/9 indicating marginal financial health, and no available Altman Z-Score limits distress risk assessment. The stock shows strong profitability metrics including a 27.18% profit margin and 39.56% operating margin, alongside robust earnings growth of 29% YoY and solid dividend yield of 3.78%. However, elevated valuation multiples relative to peers, lack of key financial data (debt/equity, cash flow), and bearish insider activity temper optimism. While growth and profitability are strong, structural data gaps and insider selling warrant caution despite positive earnings momentum.